Cavinton and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Cavinton (vinpocetine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Euthyrox, and have Hepatitis c.

The phase IV clinical study analyzes which people have Weakness when taking Cavinton. It is created by eHealthMe based on reports of 273 people who have side effects when taking Cavinton from the FDA, and is updated regularly.

What is Cavinton?

Cavinton has active ingredients of vinpocetine. eHealthMe is studying from 281 Cavinton users. Check the latest studies of Cavinton.

What is Weakness?

Weakness is found to be associated with 3,642 drugs and 6,611 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 07, 2026

273 people reported to have side effects when taking Cavinton.
Among them, 19 people (6.96%) have Weakness.

Among these 19 people:

How long have people been on Cavinton when they have Weakness? *

What is the gender of people who have Weakness when taking Cavinton? *

female: 63.16 %
male: 36.84 %

What is the age of people who have Weakness when taking Cavinton? *

What are other drugs people take besides Cavinton? *

What are other side effects people have besides Weakness? *

Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 26.32%
Dizziness: 4 people, 21.05%
Blood Creatinine Increased: 4 people, 21.05%
Haemoglobin Decreased: 4 people, 21.05%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 21.05%
Skin Burning Sensation: 4 people, 21.05%
Dehydration (dryness resulting from the removal of water): 4 people, 21.05%
Blood Glucose Increased: 4 people, 21.05%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 21.05%
Fatigue (feeling of tiredness): 3 people, 15.79%

What are the existing conditions these people have? *

Hepatitis C: 7 people, 36.84%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 26.32%
High Blood Pressure: 4 people, 21.05%
Gastric Disorder (disease of stomach): 4 people, 21.05%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
Spinal Pain (pain in spine): 2 people, 10.53%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 10.53%
Hyperthyroidism (over activity of the thyroid gland): 2 people, 10.53%
Gout (uric acid crystals building up in the body): 2 people, 10.53%
Heart Disease: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cavinton and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cavinton:

Cavinton (281 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Cavinton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,642 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,611 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vinpocetine (the active ingredients of Cavinton) and Cavinton (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.